The original success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies heavily reliant on off-patent versions presents a challenging picture. Despite early profits were significant, the end of patents and the emergence of cheaper alternatives have eroded sales. Consequently, a thorough assessment of ongoing financ